basic+care, allergy Fexofenadine Hydrochloride Tablets, 60 mg/Antihistamine, 12HR, 100 count bot...

FDA Recall #D-0332-2022 — Class II — July 27, 2021

Recall #D-0332-2022 Date: July 27, 2021 Classification: Class II Status: Terminated

Product Description

basic+care, allergy Fexofenadine Hydrochloride Tablets, 60 mg/Antihistamine, 12HR, 100 count bottle, Made in the Czech Republic, Distributed by: Perrigo Allergan, MI 49010, NDC 0113-7425-78 UPC 3 70030 14536 2

Reason for Recall

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Recalling Firm

Perrigo Company PLC — Allegan, MI

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

62,568 containers

Distribution

Nationwide in the USA

Code Information

Lot # 0CR0510, Exp 9/30/2021; 0LR0361, Exp 04/30/2022

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated